Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Cyanotech Corporation (CYAN : OTC)
 
 • Company Description   
CYANOTECH CORP. develops and commercializes natural products from microalgae. Co. is currently producing microalgae products for the nutritional supplement and immunological diagnostics markets and is also developing microalgae-based products for the aquaculture feed/pigments, biopesticide and food coloring markets. Microalgae are a diverse group of over 30,000 species of microscopic plants which have a wide range of physiological and biochemical characteristics and naturally contain high levels of nutrients.

Number of Employees: 83

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.53 Daily Weekly Monthly
20 Day Moving Average: 1,809 shares
Shares Outstanding: 7.39 (millions)
Market Capitalization: $3.92 (millions)
Beta: 0.12
52 Week High: $0.55
52 Week Low: $0.23
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 1.98% 1.23%
12 Week 36.13% 32.41%
Year To Date 17.71% 8.77%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
73-4460 QUEEN KAAHUMANU HWY SUITE 102
-
KAILUA KONA,HI 96740
USA
ph: 808-326-1353
fax: 808-329-4533
brussell@cyanotech.com http://www.cyanotech.com
 
 • General Corporate Information   
Officers
Matthew K. Custer - President and Chief Executive Officer
Michael A. Davis - Chairman
Jennifer Miyashiro - Chief Financial Officer; Vice President and Treasu
David M. Mulder - Director
David L. Vied - Director

Peer Information
Cyanotech Corporation (GSAC)
Cyanotech Corporation (CASIF)
Cyanotech Corporation (ALCD.)
Cyanotech Corporation (OMNN)
Cyanotech Corporation (CGPI.)
Cyanotech Corporation (CATX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-DRUGS
Sector: Medical
CUSIP: 232437400
SIC: 2833
Fiscal Year
Fiscal Year End: March
Last Reported Quarter: 09/01/25
Next Expected EPS Date: 08/05/26
Share - Related Items
Shares Outstanding: 7.39
Most Recent Split Date: 11.00 (0.25:1)
Beta: 0.12
Market Capitalization: $3.92 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/05/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.51
Price/Cash Flow: 6.38
Price / Sales: 0.15
EPS Growth
vs. Year Ago Period: 100.00%
vs. Previous Quarter: 100.00%
Sales Growth
vs. Year Ago Period: 25.62%
vs. Previous Quarter: 34.66%
ROE
06/30/26 - -
03/31/26 - -16.24
12/31/25 - -21.74
ROA
06/30/26 - -
03/31/26 - -5.56
12/31/25 - -7.62
Current Ratio
06/30/26 - -
03/31/26 - 1.02
12/31/25 - 1.01
Quick Ratio
06/30/26 - -
03/31/26 - 0.42
12/31/25 - 0.29
Operating Margin
06/30/26 - -
03/31/26 - -4.82
12/31/25 - -7.14
Net Margin
06/30/26 - -
03/31/26 - -4.82
12/31/25 - -7.14
Pre-Tax Margin
06/30/26 - -
03/31/26 - -4.80
12/31/25 - -7.10
Book Value
06/30/26 - -
03/31/26 - 1.04
12/31/25 - 1.06
Inventory Turnover
06/30/26 - -
03/31/26 - 2.32
12/31/25 - 2.09
Debt-to-Equity
06/30/26 - -
03/31/26 - 0.13
12/31/25 - 0.13
Debt-to-Capital
06/30/26 - -
03/31/26 - 11.55
12/31/25 - 11.31
 

Powered by Zacks Investment Research ©